http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201792674-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6939
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6951
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1641
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1682
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6907
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
filingDate 2016-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-201792674-A1
titleOfInvention METHOD OF FORMATION OF CYCLOSPORIN A / CYCLODEXTRIN NANOPARTICLES
abstract Methods for the formation of nanoparticles and microparticles of cyclosporine / cyclodextrin complexes and the introduction of the resulting suspension of nano- and microparticles into the eye of a human or animal in the form of aqueous eye drops, suitable for stimulating or enhancing the production of tears and for treating diseases of the eyes and surrounding areas. The composition of aqueous eye drops contains cyclosporine and a mixture of α-cyclodextrin and γ-cyclodextrin, as well as one or more stabilizing polymers, α-cyclodextrin solubilizes cyclosporin, and γ-cyclodextrin activates the formation of aggregates of cyclosporin / cyclodextrin complexes. The polymers stabilize the aqueous suspension of nano - and microparticles.
priorityDate 2015-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540045
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507527
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5287407
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444913
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583841

Total number of triples: 26.